SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
Highly accurate antibody tests for SARS-CoV-2 are needed for surveillance in low-prevalence populations. Here, the authors find seroprevalence of less than 1% in two San Francisco Bay Area populations at the beginning of April, and that seroreactivity is generally predictive of in vitro neutralising...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b4b0b2c17edb43c98ec84b755fb3600a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b4b0b2c17edb43c98ec84b755fb3600a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:b4b0b2c17edb43c98ec84b755fb3600a2021-12-02T17:23:48ZSARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood10.1038/s41467-020-18468-82041-1723https://doaj.org/article/b4b0b2c17edb43c98ec84b755fb3600a2020-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-18468-8https://doaj.org/toc/2041-1723Highly accurate antibody tests for SARS-CoV-2 are needed for surveillance in low-prevalence populations. Here, the authors find seroprevalence of less than 1% in two San Francisco Bay Area populations at the beginning of April, and that seroreactivity is generally predictive of in vitro neutralising activity.Dianna L. NgGregory M. GoldgofBrian R. ShyAndrew G. LevineJoanna BalcerekSagar P. BapatJohn ProstkoMary RodgersKelly CollerSandra PearceSergej FranzLi DuMars StoneSatish K. PillaiAlicia Sotomayor-GonzalezVenice ServellitaClaudia Sanchez San MartinAndrea GranadosDustin R. GlasnerLucy M. HanKent TruongNaomi AkagiDavid N. NguyenNeil M. NeumannDaniel QaziElaine HsuWei GuYale A. SantosBrian CusterValerie GreenPhillip WilliamsonNancy K. HillsChuanyi M. LuJeffrey D. WhitmanSusan L. StramerCandace WangKevin ReyesJill M. C. HakimKirk SujishiFariba AlazzehLori PhamEdward ThornborrowChing-Ying OonSteve MillerTheodore KurtzGraham SimmonsJohn HackettMichael P. BuschCharles Y. ChiuNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-7 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Science Q |
| spellingShingle |
Science Q Dianna L. Ng Gregory M. Goldgof Brian R. Shy Andrew G. Levine Joanna Balcerek Sagar P. Bapat John Prostko Mary Rodgers Kelly Coller Sandra Pearce Sergej Franz Li Du Mars Stone Satish K. Pillai Alicia Sotomayor-Gonzalez Venice Servellita Claudia Sanchez San Martin Andrea Granados Dustin R. Glasner Lucy M. Han Kent Truong Naomi Akagi David N. Nguyen Neil M. Neumann Daniel Qazi Elaine Hsu Wei Gu Yale A. Santos Brian Custer Valerie Green Phillip Williamson Nancy K. Hills Chuanyi M. Lu Jeffrey D. Whitman Susan L. Stramer Candace Wang Kevin Reyes Jill M. C. Hakim Kirk Sujishi Fariba Alazzeh Lori Pham Edward Thornborrow Ching-Ying Oon Steve Miller Theodore Kurtz Graham Simmons John Hackett Michael P. Busch Charles Y. Chiu SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood |
| description |
Highly accurate antibody tests for SARS-CoV-2 are needed for surveillance in low-prevalence populations. Here, the authors find seroprevalence of less than 1% in two San Francisco Bay Area populations at the beginning of April, and that seroreactivity is generally predictive of in vitro neutralising activity. |
| format |
article |
| author |
Dianna L. Ng Gregory M. Goldgof Brian R. Shy Andrew G. Levine Joanna Balcerek Sagar P. Bapat John Prostko Mary Rodgers Kelly Coller Sandra Pearce Sergej Franz Li Du Mars Stone Satish K. Pillai Alicia Sotomayor-Gonzalez Venice Servellita Claudia Sanchez San Martin Andrea Granados Dustin R. Glasner Lucy M. Han Kent Truong Naomi Akagi David N. Nguyen Neil M. Neumann Daniel Qazi Elaine Hsu Wei Gu Yale A. Santos Brian Custer Valerie Green Phillip Williamson Nancy K. Hills Chuanyi M. Lu Jeffrey D. Whitman Susan L. Stramer Candace Wang Kevin Reyes Jill M. C. Hakim Kirk Sujishi Fariba Alazzeh Lori Pham Edward Thornborrow Ching-Ying Oon Steve Miller Theodore Kurtz Graham Simmons John Hackett Michael P. Busch Charles Y. Chiu |
| author_facet |
Dianna L. Ng Gregory M. Goldgof Brian R. Shy Andrew G. Levine Joanna Balcerek Sagar P. Bapat John Prostko Mary Rodgers Kelly Coller Sandra Pearce Sergej Franz Li Du Mars Stone Satish K. Pillai Alicia Sotomayor-Gonzalez Venice Servellita Claudia Sanchez San Martin Andrea Granados Dustin R. Glasner Lucy M. Han Kent Truong Naomi Akagi David N. Nguyen Neil M. Neumann Daniel Qazi Elaine Hsu Wei Gu Yale A. Santos Brian Custer Valerie Green Phillip Williamson Nancy K. Hills Chuanyi M. Lu Jeffrey D. Whitman Susan L. Stramer Candace Wang Kevin Reyes Jill M. C. Hakim Kirk Sujishi Fariba Alazzeh Lori Pham Edward Thornborrow Ching-Ying Oon Steve Miller Theodore Kurtz Graham Simmons John Hackett Michael P. Busch Charles Y. Chiu |
| author_sort |
Dianna L. Ng |
| title |
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood |
| title_short |
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood |
| title_full |
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood |
| title_fullStr |
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood |
| title_full_unstemmed |
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood |
| title_sort |
sars-cov-2 seroprevalence and neutralizing activity in donor and patient blood |
| publisher |
Nature Portfolio |
| publishDate |
2020 |
| url |
https://doaj.org/article/b4b0b2c17edb43c98ec84b755fb3600a |
| work_keys_str_mv |
AT diannalng sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT gregorymgoldgof sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT brianrshy sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT andrewglevine sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT joannabalcerek sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT sagarpbapat sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT johnprostko sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT maryrodgers sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT kellycoller sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT sandrapearce sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT sergejfranz sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT lidu sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT marsstone sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT satishkpillai sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT aliciasotomayorgonzalez sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT veniceservellita sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT claudiasanchezsanmartin sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT andreagranados sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT dustinrglasner sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT lucymhan sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT kenttruong sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT naomiakagi sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT davidnnguyen sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT neilmneumann sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT danielqazi sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT elainehsu sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT weigu sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT yaleasantos sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT briancuster sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT valeriegreen sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT phillipwilliamson sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT nancykhills sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT chuanyimlu sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT jeffreydwhitman sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT susanlstramer sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT candacewang sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT kevinreyes sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT jillmchakim sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT kirksujishi sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT faribaalazzeh sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT loripham sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT edwardthornborrow sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT chingyingoon sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT stevemiller sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT theodorekurtz sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT grahamsimmons sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT johnhackett sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT michaelpbusch sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood AT charlesychiu sarscov2seroprevalenceandneutralizingactivityindonorandpatientblood |
| _version_ |
1718380990257168384 |